Bombshell Interview Reveals DNA Fragments Discovered 6 Months After Vaccination

By Catherine J. Frompovich | August 16th, 2012

Interview With

Norma Erickson, President, S.A.N.E. VAX, Inc

Part 1 | Part 2

Sin Hang Lee, MD, is a medical practitioner historically qualified to practice medicine in the People’s Republic of China, the District of Columbia, New York State, and the State of Connecticut in the USA, plus in Canada and British Commonwealth countries via his registration with the General Medical Council of the UK. Currently Dr. Lee holds a medical license in the State of Connecticut, USA.

Dr. Lee has staff privileges at the Milford Hospital in Milford, Connecticut. He was certified by the American Board of Pathology in anatomical pathology (1966); certified in general pathology by the Royal College of Physicians and Surgeons of Canada (1966); and granted the F.R.C.P. degree by the Royal College of Physicians and Surgeons of Canada (1966). Dr. Lee has practiced diagnostic pathology in Canada and the USA continuously since 1966 with a special interest in developing new technologies in laboratory medicine. His most recent research is the use of low temperature (LoTemp®) polymerase chain reaction (PCR) and direct automated Sanger DNA sequencing to increase the sensitivity and specificity of the molecular diagnosis of infectious diseases.

Using Dr. Lee’s new methods, PCR can detect HPV L1 gene DNA bound to nanoparticles; it can detect HPV L1 gene DNA of vaccine origin present in human blood and tissue samples.

Norma, given the above professional bio about Dr. Lee, one has to assume he is more than qualified to discuss his findings with regard to the Jasmine Renata case in New Zealand. I understand Dr. Lee was one of numerous experts and witnesses to testify at the recent (August 9, 2012) two-day inquest held to determine the cause of death, which could not be determined officially by autopsy. This case has gathered local interest and coverage. I understand the New Zealand press covered the event in real-time and reported on it. Here are two links to that coverage.

The Dominion Post

http://www.stuff.co.nz/dominion-post/news/7437620/Teens-brain-tissue-sent-for-examination

Ostago Daily Times

http://www.odt.co.nz/news/national/220882/biological-plausibility-vaccine-caused-death

Since we cannot discuss the inquest until the coroner releases that information, let’s talk about some of what we know. Dr. Lee tested 16 samples of Gardasil^® in use from 9 countries, each with a different lot number. The lot numbers of the 5 New Zealand samples, the cities of origin and the HPV genotypes of the L1 gene DNA found in each sample are listed below:

There seems to be a potential problem that falls back on to the Renata case insofar as Dr. Lee’s findings in Jasmine’s blood and spleen tissue and the above findings. Can you please tell us about that?

Yes, Catherine, there are multiple potential problems with discovering HPV-16 L1 DNA in Jasmine’s samples. We must emphasize that what was discovered in the Gardasil® vaccine and in Jasmine’s samples are viral DNA fragments, not the infective wild viruses.

First, HPV infection is confined to epithelium. This virus does not survive in the blood or in other organs of a healthy woman. Any naked HPV DNA fragments in the circulating blood would be degraded by serum or intracellular DNA nucleases (enzymes) if these fragments are taken up by the macrophages (a component of the white blood cells), and eliminated from the body in 24-48 hours.

Since the HPV-16 L1 gene DNA fragments were discovered 6 months after Jasmine’s last Gardasil^® vaccination, we have to assume these HPV DNA fragments were either protected by being firmly bound to the aluminum adjuvant, or by integrating themselves into the human genome through poorly understood mechanisms.

Didn’t Jasmine’s mother contact Dr. Lee after she had read that the U.S. FDA announced that the Gardasil® vaccine contained residues of HPV L1 gene DNA?

Jasmine’s parents made contact with us after the discovery of genetically engineered HPV DNA in Gardasil® through an associate we work with in New Zealand. They were then put in direct contact with Dr. Lee because of his expertise.

I think our readers ought to know that the FDA affirmed Gardasil® samples do contain HPV L1 gene DNA fragments. That can be confirmed on FDA’s website:

http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm276859.htm

Wasn’t that an ‘after-the-fact’ FDA announcement to its certifying that Gardasil® was safe and effective, despite it being bound to insoluble adjuvant AAHS particles? How could that have slipped by the certifying process? I guess that does not appear on the vaccine package insert, does it?

The webpage you refer to was a public response to the SaneVax letter which informed the FDA of the contaminants Dr. Lee had discovered. Anyone reading the FDA’s announcement should note there are absolutely no scientific references to back up the claims, and I quote, “The presence of these DNA fragments is expected, is not a risk to vaccine recipients, and is not a safety factor.”

In stark contrast, readers can examine our original letter informing the FDA of this potential health risk here:

http://sanevax.org/sane-vax-to-fda-recombinant-hpv-dna-found-in-multiple-samples-of-gardasil/

Instead of conducting further investigation into our discoveries, including the finding of HPV DNA fragments firmly bound to the insoluble AAHS adjuvant, the FDA issued a blanket statement as to the vaccine’s safety.

AAHS is listed as an adjuvant on the package insert. But a molecular complex of HPV DNA or plasmid DNA fragments firmly bound to the AAHS particles (probably through a chemical reaction) are not.

Don’t those insoluble adjuvant AAHS [amorphous aluminum hydroxyphosphate sulfate] particles and the HPV L1 gene DNA encourage cytokine production, which apparently is not listed on the vaccine package insert?

AAHS is Merck’s proprietary mineral-based insoluble adjuvant with a very high binding capacity for HPV VLPs, the active major capsid protein antigen in Gardasil®. The vaccine manufacturer and the FDA might have known there would be residual HPV DNA and plasmid DNA in the Gardasil® vaccine, if there is evidence to support that claim.

However, they did not know (or, if they knew, did not disclose) the physical condition of these naked viral (HPV) and bacterial (plasmid) DNA in Gardasil®. For example, these DNA fragments could be in the aqueous phase (dissolved in water), encapsulated in the VLPs, or bound to the AAHS by electrostatic attraction or an irreversible chemical reaction between the aluminum in the AAHS and the phosphate backbone of the DNA molecules.

In his testimony, Dr. Lee presented experimental evidence to show that DNA/AAHS complexes may constitute a new chemical compound with unknown effects. As all AAHS nanoparticles are designed to be phagocytized by tissue macrophages after intramuscular injection, any foreign viral and/or plasmid DNA present would be carried into the cytoplasm of the macrophages along with the AAHS nanoparticles. Once in the cytoplasm, these foreign DNA fragments, protected from degradation, may act as long-acting stimulators to activate the macrophages to signal the production of cytokines, such as tumor necrosis factor (TNF).

TNF is a known myocardial depressant capable of causing hypotension and lethal shock in animals and in humans, as well as other symptoms commonly reported by the girls vaccinated with Gardasil^®.

Persistence of foreign DNA fragments in the cells increases the chance of integration of the foreign DNA into the human genome through poorly understood mechanisms, thus increasing the risk of gene mutations and cancer.

MORE HERE